Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Главные авторы: | S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Elsevier
2020-07-01
|
Серии: | European Urology Open Science |
Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2666168320336442 |
Схожие документы
-
N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
по: Hirotake Kodama, и др.
Опубликовано: (2021-02-01) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
по: Shingo Hatakeyama, и др.
Опубликовано: (2013-01-01) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
по: Itsuto Hamano, и др.
Опубликовано: (2020-07-01) -
Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
по: Takuma Narita, и др.
Опубликовано: (2017-04-01) -
Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
по: H. Yamamoto, и др.
Опубликовано: (2020-07-01)